TTI and OTCM Related Headlines
Go Back- Thiogenesis Announces FDA Clearance of IND for Nephropathic Cystinosis
- Thiogenesis Reports Results of 2026 Annual and Special Meeting of Shareholders and Provides Corporate Update
TTI and OTCM Related Press Releases
Go Back- Thiogenesis Announces FDA Clearance of IND for Nephropathic Cystinosis
- Thiogenesis Reports Results of 2026 Annual and Special Meeting of Shareholders and Provides Corporate Update


